No Data
No Data
Youcare Pharmaceutical Group Co., Ltd.'s (SHSE:688658) Price Is Right But Growth Is Lacking
Half-year report for the year 2024.
Summary of Half-Year Report in 2024.
These 4 Measures Indicate That Youcare Pharmaceutical Group (SHSE:688658) Is Using Debt Reasonably Well
Open Source Securities: Bullish on the opportunity of PCSK9 inhibitors in the lipid-lowering market.
Bullish on the opportunity of PCSK9 inhibitors in the lipid-lowering market, with a focus on the market potential of siRNA drugs with higher adherence. Leading companies with strategic layout are expected to benefit.
Pharmaceuticals that effectively treat tinnitus are extremely rare in the market for Youcare Pharmaceutical (688658.SH).
On August 6, Gelonghui reported that Youcare Pharmaceutical Group (688658.SH) stated in an investor relations activity that the main departments currently using Ginkgo biloba leaf extract injection in hospitals are neurology and cardiovascular medicine. In the future, with the increase of the promotion of tinnitus treatment, it is expected that the usage of Ginkgo biloba leaf extract injection will increase significantly in departments such as otorhinolaryngology and geriatrics. Because the Ginkgo biloba leaf extract injection has been introduced to hospitals, the difficulty of increasing department coverage in the future is relatively small, which is conducive to further promotion of the product. Currently, in the field of tinnitus treatment, effective drugs for tinnitus are very rare on the market.
No Data
No Data